Annual Report

Overview

The report describes AstraZeneca Pharma India Limited's FY2021-22 pharmaceutical performance, including sales of ₹ 7,614 million and total comprehensive income of ₹ 599 million. The company had 1,183 employees and spent ₹ 20.74 million on CSR projects covering healthcare access, education and environmental protection. Its environmental initiatives included rooftop solar power, renewable-energy use at the manufacturing site, water reuse and tree planting.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: Ends 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services